Gut Microbiome in Extremely Low-Birth-Weight Infants Influences Lung Damage Development

New research links gut fungi in very-low-birth-weight infants to the development of lung damage, suggesting potential for innovative therapies targeting the microbiome.
Recent research published in the journal Microbiome reveals a significant link between the gut fungi microbiome, known as the mycobiome, in very-low-birth-weight (VLBW) preterm infants and the development of oxygen-induced lung injury, particularly bronchopulmonary dysplasia (BPD). Extremely preterm infants, especially those weighing less than 3.3 pounds, often require high oxygen levels and mechanical ventilation, which can damage immature lungs and lead to BPD, a leading cause of mortality among these vulnerable infants.
In a comprehensive study conducted by researchers from the University of Alabama at Birmingham and the University of Tennessee Health Science Center, the gut fungi present in the second week of life, before clinical symptoms of BPD appear, were analyzed. The study examined stool samples collected from infants within the first two weeks after birth. Findings indicated that the diversity and composition of the infants' gut mycobiome differed markedly between those who later developed BPD and those who did not. Notably, bacterial differences were not significant in early stool samples.
To explore causality, researchers transferred stool samples—either associated with BPD prediction or not—into female mice to observe the effects. Mice receiving stool associated with BPD exhibited more severe lung injury, echoing the human condition. Furthermore, when antifungal treatments were administered to the dams of these pups, the severity of lung damage was reduced, suggesting that fungi play a causal role in lung injury. Conversely, increasing fungal colonization with a Candida species intensified lung injury in the mouse model.
Dr. Kent Willis, one of the lead researchers, commented that initial fungal colonization patterns in the gut might influence the development of BPD in preterm infants. The research highlights the potential for targeting the gut mycobiome as a therapeutic strategy to prevent or mitigate lung damage in these infants. The study underscores that a balanced and uniform fungal community may confer resistance to BPD, while discordant mycobiomes could predispose infants to disease.
This investigation adds a new dimension to understanding neonatal lung disease, emphasizing the importance of the gut microbiota, particularly fungi, in early development and long-term health outcomes in preterm infants.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rise in Measles Cases in California Surpasses Entire 2024 Total
California reports over 16 measles cases in 2025, surpassing the total for all of 2024, amid ongoing outbreaks and declining vaccination rates. Learn more about this concerning resurgence.
Innovative Drug Shows Promise in Managing Resistant Hypertension
A new clinical trial highlights lorundrostat's potential to safely lower blood pressure in patients with resistant hypertension, marking a significant advancement in targeted hypertension therapy.
Study Links Higher Cardiovascular Risks to Common Diabetes Medication Glipizide
A new study finds that the diabetes medication glipizide is linked to higher cardiovascular risks compared to DPP-4 inhibitors, highlighting the importance of personalized treatment decisions for type 2 diabetes patients.
New Guidance for GPs on Managing Patients Using Weight-Loss Injections
Experts provide new guidance for GPs on managing patients using privately obtained weight-loss injections, emphasizing recognition, safe management, and comprehensive care strategies.